Literature DB >> 15030309

CD1d-mediated antigen presentation to natural killer T (NKT) cells.

Randy R Brutkiewicz1, Yinling Lin, Sungyoo Cho, Yu Kyeong Hwang, Venkataraman Sriram, Tonya J Roberts.   

Abstract

CD1d molecules are lipid antigen-presenting molecules. They are involved in presenting these antigens to a unique subpopulation of T cells called natural killer T (NKT) cells, which have the capacity to produce both T helper (Th) 1 and Th2 cytokines. Thus, it is possible that the antigens presented by CD1d and/or the level at which they are presented could have profound effects on the immunoregulation of autoimmune and infectious diseases, as well as cancer. Because of the ability of CD1d-binding ligands to modulate NKT cell responses, targeting CD1d-mediated antigen presentation as a novel approach for new therapies in these and other diseases holds great promise.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15030309     DOI: 10.1615/critrevimmunol.v23.i56.30

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  18 in total

1.  Apoptosis-induced inhibition of CD1d-mediated antigen presentation: different roles for caspases and signal transduction pathways.

Authors:  Masood A Khan; Venkataraman Sriram; Gourapura J Renukaradhya; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  Immunology       Date:  2008-03-14       Impact factor: 7.397

2.  CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.

Authors:  Petr O Ilyinskii; Ruojie Wang; Steven P Balk; Mark A Exley
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  A threonine-based targeting signal in the human CD1d cytoplasmic tail controls its functional expression.

Authors:  Jianyun Liu; Daniel Shaji; Sungyoo Cho; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

4.  JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells.

Authors:  Jianyun Liu; Richard M Gallo; Masood A Khan; Abhirami K Iyer; Ian M Kratzke; Randy R Brutkiewicz
Journal:  Eur J Immunol       Date:  2018-12-03       Impact factor: 5.532

5.  Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway.

Authors:  Masood A Khan; Richard M Gallo; Randy R Brutkiewicz
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

6.  Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Daniel Shaji; Randy R Brutkiewicz
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

7.  Induction of natural killer cell responses by ectromelia virus controls infection.

Authors:  April Keim Parker; Scott Parker; Wayne M Yokoyama; John A Corbett; R Mark L Buller
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

8.  Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Marcus Vieira; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  Blood       Date:  2008-04-16       Impact factor: 22.113

Review 9.  The host response and molecular pathogenesis associated with respiratory syncytial virus infection.

Authors:  Christine M Oshansky; Wenliang Zhang; Elizabeth Moore; Ralph A Tripp
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

10.  Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation.

Authors:  Masood A Khan; Richard M Gallo; Gourapura J Renukaradhya; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.